Fortress Biotech, Inc. (FBIO) Revenue Growth
Fortress Biotech, Inc. (FBIO) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | -47.68% |
| 2018-12-31 | -79.67% |
| 2019-12-31 | -51.28% |
| 2020-12-31 | -37.47% |
| 2021-12-31 | 429.68% |
| 2022-12-31 | 1188.26% |
| 2023-12-31 | -18.13% |
| 2024-12-31 | -7.59% |
| 2025-12-31 | 11.07% |
How FBIO compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| EW | Edwards Lifesciences Corporation | 11.55% |
| NEO | NeoGenomics Inc. | 10.11% |
| VRTX | Vertex Pharmaceuticals Incorporated | 8.90% |
| ABBV | AbbVie Inc. | 8.57% |
| MDT | Medtronic plc. | 8.43% |
These are five companies in the same sector as FBIO with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Fortress Biotech, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("FBIO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | FBIO | $2.73 | +1.87% | 0.28M |
| 3 | ||||
| 4 | ||||
| 5 |